211 related articles for article (PubMed ID: 7983499)
1. Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Del Poeta M; Barchiesi F; Morbiducci V; Arzeni D; Marinucci G; Ancarani F; Scalise G
J Chemother; 1994 Jun; 6(3):173-6. PubMed ID: 7983499
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
[TBL] [Abstract][Full Text] [Related]
3. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Fromtling RA; Abruzzo GK; Bulmer GS
Mycopathologia; 1986 Apr; 94(1):27-30. PubMed ID: 3014339
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
Abdel-Salam HA
Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Swinne D; Raes-Wuytack C; Van Looveren K; Desmet P
Mycoses; 1999; 42(4):231-7. PubMed ID: 10424089
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
Poon M; Cronin DC; Wormser GP; Bottone EJ
Arch Pathol Lab Med; 1988 Feb; 112(2):161-2. PubMed ID: 3276290
[TBL] [Abstract][Full Text] [Related]
10. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
Souza LK; Fernandes Ode F; Kobayashi CC; Passos XS; Costa CR; Lemos JA; Souza-Júnior AH; Silva Mdo R
Rev Inst Med Trop Sao Paulo; 2005; 47(5):253-6. PubMed ID: 16302107
[TBL] [Abstract][Full Text] [Related]
12. Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.
Anaissie E; Shawar R; Paetznick V; Ensign LG; Witte Z; LaRocco M
J Clin Microbiol; 1993 May; 31(5):1370-2. PubMed ID: 8501245
[TBL] [Abstract][Full Text] [Related]
13. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs].
Bava AJ; Negroni R
Rev Inst Med Trop Sao Paulo; 1989; 31(5):346-50. PubMed ID: 2560840
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method.
López-Jodra O; Torres-Rodríguez JM; Méndez-Vásquez R; Ribas-Forcadell E; Morera-López Y; Baró-Tomás T; Alia-Aponte C
J Antimicrob Chemother; 2000 May; 45(5):645-9. PubMed ID: 10797087
[TBL] [Abstract][Full Text] [Related]
15. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Kantarcioğlu AS; Boekhout T; Yücel A; Altas K
Med Mycol; 2009 Mar; 47(2):169-76. PubMed ID: 18654925
[TBL] [Abstract][Full Text] [Related]
17. Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans.
St-Germain G; Dion C
Mycoses; 1996; 39(5-6):201-6. PubMed ID: 8909030
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.
Boon-Long J; Mekha N; Poonwan N; Kusum M; Mikami Y; Yazawa K; Konyama K
Mycoses; 1996; 39(11-12):453-6. PubMed ID: 9145003
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital].
Silva PR; Rabelo RA; Terra AP; Teixeira DN
Rev Soc Bras Med Trop; 2008; 41(2):158-62. PubMed ID: 18545836
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Barchiesi F; Tortorano AM; Di Francesco LF; Cogliati M; Scalise G; Viviani MA
J Antimicrob Chemother; 1999 Feb; 43(2):295-9. PubMed ID: 11252339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
